alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › pharmacological

pharmacological

5 studies tagged pharmacological, dated 2002-09-01 to 2025-02-02. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. How to advance the pharmacological management of cognitive impairment in Parkinson's disease 2025-02-02
  2. Microglia: A pharmacological target for the treatment of age-related cognitive decline and Alzheimer's disease 2023-02-09
  3. Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-Amyloid plaques in an early-onset Alzheimer's disease mouse model 2019-12-04

Studies

5 studies carry this tag.

Date range

2002 to 2025

Top journals

  • Aging 1
  • Current drug metabolism 1
  • Frontiers in pharmacology 1
  • Journal of Parkinson's disease 1
  • Pharmacological reviews 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. How to advance the pharmacological management of cognitive impairment in Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Journal of Parkinson's disease 2025-02-02 Cognitive tests and assessment

    Cognitive impairment is a common non-motor symptom in people with Parkinson's disease (PD) and is associated to poor clinical outcomes.

  2. Microglia: A pharmacological target for the treatment of age-related cognitive decline and Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Frontiers in pharmacology 2023-02-09 TREM2 and immune genetics

    As individuals age, microglia, the resident immune cells of the central nervous system (CNS), become less effective at preserving brain circuits.

  3. Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-Amyloid plaques in an early-onset Alzheimer's disease mouse model

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Aging 2019-12-04 Biomarkers

    The implication of epigenetic mechanisms in Alzheimer's disease (AD) has been demonstrated in several studies.

  4. Pharmacological targeting of IDO-mediated tolerance for treating autoimmune disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Current drug metabolism 2007-04-01 TREM2 and immune genetics

    This stops local T cell proliferation to ultimately result in the most dramatic example of immune tolerance, acceptance of the fetus.

  5. Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Pharmacological reviews 2002-09-01 Risk genes beyond APOE

    Alzheimer's disease (AD) is the most common cause of dementia that arises on a neuropathological background of amyloid plaques containing beta-amyloid (A beta) derived from amyloid precursor protein (APP) and tau-rich neurofibrillary tangles.

All topic tags with their study counts